Estimating the cost of complications of diabetes in Australia using administrative health-care data

Value in Health

Volumn 11, Issue 2, 2008, Pages 199-206

  Clarke, Philip ^a   Leal, Jose ^b   Kelman, Chris ^c   Smith, Merran ^d   Colagiuri, Stephen ^e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c The Australian National University   (Australia)

^d DEPARTMENT OF HEALTH   (Australia)

^e PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Australia; Diabetes mellitus; Diabetes related complications; Health care costs; Record linkage

Indexed keywords

ADULT; AMPUTATION; ARTICLE; AUSTRALIA; BILLING AND CLAIMS; BLINDNESS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH CARE; HEALTH CARE COST; HEALTH INSURANCE; HEART FAILURE; HEART INFARCTION; HOSPITAL SERVICE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; STROKE;

EID: 41549140081     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2007.00228.x     Document Type: Article

References (25)

1. Gold MR, Siegel JE, Russell L, Weinstein MC. Cost-Effectiveness in Health and Medicine. Oxford : Oxford University Press, 1996.
2. CDC Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 2002 287 : 2542 51.
3. Clarke PM, Gray AM, Briggs A, et al. Cost-utility analyses of intensive blood glucose and tight blood pressure control in Type 2 diabetes (UKPDS 72). Diabetologia 2005 48 : 868 77.
4. American Diabetes Association Consensus Panel. Guidelines for computer modeling of diabetes and its complications. Diabetes Care 2004 27 : 2262 5.
5. Clarke PM, Gray AM, Briggs A, et al. A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom prospective diabetes study (UKPDS 68) Outcomes Model. Diabetologia 2004 47 : 1747 59.
6. Palmer AJ, Roze S, Valentine WJ, et al. The CORE diabetes model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (Type 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res 2004 20 (Suppl. S5 26.
7. Ray JA, Valentine WJ, Secdnik K, et al. Review of the cost of diabetes complications in Australia, Canada, France, Germany Italy and Spain. Curr Med Res Opin 2005 21 : 1617 29.
8. Commonwealth Department of Health and Family Services. Development of the Australian Refined Diagnosis Related Groups (AR-DRG) Classification Version 4: Volume 1. Canberra : Commonwealth of Australia, 1998.
9. Weinstein MC, O'Brien B, Hornberger J, et al. Principles of good practice of decision analytic modelling in health care evaluation: report of the ISPOR task force on good research practices-modeling studies. Value Health 2003 6 : 9 17.
10. Kelman CW, Bass AJ, Holman CD. Research use of linked health data - a best practice protocol. Aust N Z J Public Health 2002 26 : 251 5.
11. Australian Bureau of Statistics. 2001 Census Basic Community Profiles and Snapshots. 2002. Available from: http://www.Abstract.gov.au/ [Accessed September 14, 2005].
12. Clarke P, Gray A, Legood R, et al. The impact of diabetes-related complications on health care costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study, 65). Diabet Med 2003 20 : 442 50.
13. O'Brien JA, Shomphe LA, Kavanagh PL, et al. Direct medical costs of complications from type 2 diabetes mellitus in the US. Diabetes Care 1998 21 : 1122 8.
14. Preen DB, Holman CD, Lawrence DM, et al. Hospital chart review provided more accurate comorbidity information than data from a general practitioner survey or an administrative database. J Clin Epidemiol 2004 57 : 1295 304.
15. Commonwealth Department of Health and Aged Care. Report on the national hospital cost data collection 1997-1998 (Round 2). Canberra : AGPS, 1999.
16. Duckett SJ. Casemix funding for acute hospital inpatient services in Australia. Med J Aust 1998 169 (Suppl. S17 21.
17. Australian Bureau of Statistics. Consumer Price Index, Australia. 2005. Available from: http://www.Abstract.gov.au [Accessed September 14, 2005].
18. Hsiao C. Analysis of Panel Data (2nd ed.). Cambridge : Cambridge University Press, 2003.
19. Basu A, Rathouz PJ. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostatistics 2005 6 : 93 109.
20. Mullahy J. Much ado about two: reconsidering retransformation and the two-part model in health econometrics. J Health Econ 1998 17 : 247 81.
21. Commonwealth Department of Human Services and Health. Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee Including Major Submissions Involving Economic Analyses. Canberra : Australian Government Publishing Service, 1995.
22. Clarke P, Kelman C, Colagiuri S. Factors influencing the cost of hospital care for people with diabetes in Australia. J Diabetes Complications 2006 20 : 349 55.
23. Morris AD, Boyle DIR, McAlpine R, et al. The diabetes audit in Tayside Scotland (darts) study: electronic record linkage to create a diabetes register. BMJ 1997 315 : 524 8.
24. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance. The Australian Diabetes, Obesity Lifestyle Study (AUSDIAB). Diabetes Care 2002 25 : 829 34.
25. Phelps CE. Information diffusion and best practice adoption. In : Culyer AJ, Newhouse JP, eds. Handbook of Health Economics. Amsterdam : Elsevier, 2000.